Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Stroncek

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Cytotherapy|December 3, 2023
Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative studyBeth H Shaz, Richard Schäfer, Magali J Fontaine, et al.
Journal of Translational Medicine|May 8, 2007
Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among TunisiansXin Li, Nahla Ghandri, Daniela Piancatelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
American Journal of Hematology|July 2, 2013
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromesJeremy Pantin, Xin Tian, Avni A Shah, et al.
Cytotherapy|April 13, 2013
Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) CollaborativeDerwood Pamphilon, Eileen Selogie, David McKenna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34<sup>+</sup> Selection versus CD3<sup>+</sup>/19<sup>+</sup> Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell TransplantationCaroline R Cantilena, Sawa Ito, Xin Tian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Stem Cells (Dayton, Ohio)|January 24, 2014
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responsesFang Yin, Minoo Battiwalla, Sawa Ito, et al.
British Journal of Haematology|February 8, 2017
Allogeneic transplantation using CD34<sup>+</sup> selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemiaEnkhtsetseg Purev, Xin Tian, Georg Aue, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancerSylvia Adams, Sandra Demaria, Darawan Rinchai, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Cytotherapy|December 3, 2023
Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative studyBeth H Shaz, Richard Schäfer, Magali J Fontaine, et al.
Journal of Translational Medicine|May 8, 2007
Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among TunisiansXin Li, Nahla Ghandri, Daniela Piancatelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2014
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuriaJeremy Pantin, Xin Tian, Nancy Geller, et al.
American Journal of Hematology|July 2, 2013
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromesJeremy Pantin, Xin Tian, Avni A Shah, et al.
Cytotherapy|April 13, 2013
Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) CollaborativeDerwood Pamphilon, Eileen Selogie, David McKenna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34<sup>+</sup> Selection versus CD3<sup>+</sup>/19<sup>+</sup> Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell TransplantationCaroline R Cantilena, Sawa Ito, Xin Tian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Stem Cells (Dayton, Ohio)|January 24, 2014
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responsesFang Yin, Minoo Battiwalla, Sawa Ito, et al.
British Journal of Haematology|February 8, 2017
Allogeneic transplantation using CD34<sup>+</sup> selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemiaEnkhtsetseg Purev, Xin Tian, Georg Aue, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancerSylvia Adams, Sandra Demaria, Darawan Rinchai, et al.
Pageof 10